Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53

BACKGROUND: Primary radiotherapy (RT) is a mainstay of treatment for laryngeal squamous cell carcinoma (LSCC). Although the cure rates for early (T1) vocal cord tumours are high, RT proves ineffective in up to a third of T3 carcinomas. Moreover, RT is associated with debilitating early- and late-tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Arya, A K, El-Fert, A, Devling, T, Eccles, R M, Aslam, M A, Rubbi, C P, Vlatković, N, Fenwick, J, Lloyd, B H, Sibson, D R, Jones, T M, Boyd, M T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906734/
https://www.ncbi.nlm.nih.gov/pubmed/20588277
http://dx.doi.org/10.1038/sj.bjc.6605739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906734/
https://www.ncbi.nlm.nih.gov/pubmed/20588277
http://dx.doi.org/10.1038/sj.bjc.6605739

Ejemplares similares